{"draw":1,"recordsFiltered":12762,"recordsTotal":12762,"data":[{"__attributes":{"id":"post-row-86020","class":"post-row post-type-post post-86020 publish"},"date":" 13 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755.png\" class=\"\" alt=\"FDA Advisory No.2024-0755 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cKidneys Nano 20 Effervescent\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0755\" data-caption=\"FDA Advisory No.2024-0755 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cKidneys Nano 20 Effervescent\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0755-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-kidneys-nano-20-effervescent\/\">FDA Advisory No.2024-0755 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cKidneys Nano 20 Effervescent\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-86016","class":"post-row post-type-post post-86016 publish"},"date":" 13 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0769.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0769.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0769.png\" class=\"\" alt=\"FDA Advisory No.2024-0769 || Public Health Warning Against the Purchase and Use of the Unnotified Medical Device Product \u201cMAXWELL LATEX EXAMINATION GLOVES\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0769\" data-caption=\"FDA Advisory No.2024-0769 || Public Health Warning Against the Purchase and Use of the Unnotified Medical Device Product \u201cMAXWELL LATEX EXAMINATION GLOVES\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0769.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0769.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0769.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0769-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0769-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0769-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0769-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0769-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0769-public-health-warning-against-the-purchase-and-use-of-the-unnotified-medical-device-product-maxwell-latex-examination-gloves\/\">FDA Advisory No.2024-0769 || Public Health Warning Against the Purchase and Use of the Unnotified Medical Device Product \u201cMAXWELL LATEX EXAMINATION GLOVES\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/device-advisories\/\" rel=\"category tag\">Device Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-86011","class":"post-row post-type-post post-86011 publish"},"date":" 13 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0768.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0768.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0768.png\" class=\"\" alt=\"FDA Advisory No.2024-0768 || Public Health Warning Against the Purchase and Use of the Unnotified Medical Device Product \u201cSAMPLE LINE, 8 FT. (2.4M)\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0768\" data-caption=\"FDA Advisory No.2024-0768 || Public Health Warning Against the Purchase and Use of the Unnotified Medical Device Product \u201cSAMPLE LINE, 8 FT. (2.4M)\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0768.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0768.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0768.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0768-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0768-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0768-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0768-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0768-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0768-public-health-warning-against-the-purchase-and-use-of-the-unnotified-medical-device-product-sample-line-8-ft-2-4m\/\">FDA Advisory No.2024-0768 || Public Health Warning Against the Purchase and Use of the Unnotified Medical Device Product \u201cSAMPLE LINE, 8 FT. (2.4M)\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/device-advisories\/\" rel=\"category tag\">Device Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85973","class":"post-row post-type-post post-85973 publish"},"date":" 9 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0761.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0761.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0761.png\" class=\"\" alt=\"FDA Advisory No.2024-0761 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement \u201cVITABEARS Sleep Vitamins (Dietary Supplement)&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-0761\" data-caption=\"FDA Advisory No.2024-0761 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement \u201cVITABEARS Sleep Vitamins (Dietary Supplement)&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0761.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0761.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0761.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0761-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0761-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0761-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0761-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0761-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0761-public-health-warning-against-the-purchase-and-consumption-of-the-unregistered-food-supplement-vitabears-sleep-vitamins-dietary-supplement\/\">FDA Advisory No.2024-0761 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement \u201cVITABEARS Sleep Vitamins (Dietary Supplement)&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/food-advisories\/\" rel=\"category tag\">Food Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85969","class":"post-row post-type-post post-85969 publish"},"date":" 9 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0760.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0760.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0760.png\" class=\"\" alt=\"FDA Advisory No.2024-0760 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement \u201cVITABEARS Skin Vitamins (Dietary Supplement)&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-0760\" data-caption=\"FDA Advisory No.2024-0760 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement \u201cVITABEARS Skin Vitamins (Dietary Supplement)&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0760.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0760.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0760.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0760-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0760-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0760-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0760-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0760-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0760-public-health-warning-against-the-purchase-and-consumption-of-the-unregistered-food-supplement-vitabears-skin-vitamins-dietary-supplement\/\">FDA Advisory No.2024-0760 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement \u201cVITABEARS Skin Vitamins (Dietary Supplement)&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/food-advisories\/\" rel=\"category tag\">Food Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85965","class":"post-row post-type-post post-85965 publish"},"date":" 9 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0759.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0759.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0759.png\" class=\"\" alt=\"FDA Advisory No.2024-0759 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement \u201cVITABEARS Flawless Glow (Dietary Supplement)&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-0759\" data-caption=\"FDA Advisory No.2024-0759 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement \u201cVITABEARS Flawless Glow (Dietary Supplement)&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0759.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0759.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0759.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0759-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0759-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0759-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0759-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0759-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0759-public-health-warning-against-the-purchase-and-consumption-of-the-unregistered-food-supplement-vitabears-flawless-glow-dietary-supplement\/\">FDA Advisory No.2024-0759 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement \u201cVITABEARS Flawless Glow (Dietary Supplement)&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/food-advisories\/\" rel=\"category tag\">Food Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85961","class":"post-row post-type-post post-85961 publish"},"date":" 9 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0757-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-0757-A\" data-caption=\"FDA Advisory No.2024-0757-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0757-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-0757-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85957","class":"post-row post-type-post post-85957 publish"},"date":" 9 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757.png\" class=\"\" alt=\"FDA Advisory No.2024-0757 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-0757\" data-caption=\"FDA Advisory No.2024-0757 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0757-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-0757 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85953","class":"post-row post-type-post post-85953 publish"},"date":" 9 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0756-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-0756-A\" data-caption=\"FDA Advisory No.2024-0756-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0756-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-0756-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85949","class":"post-row post-type-post post-85949 publish"},"date":" 9 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756.png\" class=\"\" alt=\"FDA Advisory No.2024-0756 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-0756\" data-caption=\"FDA Advisory No.2024-0756 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0756-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-0756 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85942","class":"post-row post-type-post post-85942 publish"},"date":" 8 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0752-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cNatural Eye Drops 15 mL (250 drops)\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0752-A\" data-caption=\"FDA Advisory No.2024-0752-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cNatural Eye Drops 15 mL (250 drops)\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0752-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-natural-eye-drops-15-ml-250-drops\/\">FDA Advisory No.2024-0752-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cNatural Eye Drops 15 mL (250 drops)\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85938","class":"post-row post-type-post post-85938 publish"},"date":" 8 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752.png\" class=\"\" alt=\"FDA Advisory No.2024-0752 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cNatural Eye Drops 15 mL (250 drops)\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0752\" data-caption=\"FDA Advisory No.2024-0752 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cNatural Eye Drops 15 mL (250 drops)\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0752-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-natural-eye-drops-15-ml-250-drops\/\">FDA Advisory No.2024-0752 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cNatural Eye Drops 15 mL (250 drops)\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85934","class":"post-row post-type-post post-85934 publish"},"date":" 8 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0751-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cGlutax\u00ae 4000GS Cell Rejuvenation Softgel 60\u2019s\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0751-A\" data-caption=\"FDA Advisory No.2024-0751-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cGlutax\u00ae 4000GS Cell Rejuvenation Softgel 60\u2019s\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0751-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-glutax-4000gs-cell-rejuvenation-softgel-60s\/\">FDA Advisory No.2024-0751-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cGlutax\u00ae 4000GS Cell Rejuvenation Softgel 60\u2019s\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85930","class":"post-row post-type-post post-85930 publish"},"date":" 8 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751.png\" class=\"\" alt=\"FDA Advisory No.2024-0751 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cGlutax\u00ae 4000GS Cell Rejuvenation Softgel 60\u2019s\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0751\" data-caption=\"FDA Advisory No.2024-0751 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cGlutax\u00ae 4000GS Cell Rejuvenation Softgel 60\u2019s\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0751-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-glutax-4000gs-cell-rejuvenation-softgel-60s\/\">FDA Advisory No.2024-0751 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cGlutax\u00ae 4000GS Cell Rejuvenation Softgel 60\u2019s\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85926","class":"post-row post-type-post post-85926 publish"},"date":" 8 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0750-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cPartners\u00ae Alcohol Pads 75% Ethyl Alcohol\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0750-A\" data-caption=\"FDA Advisory No.2024-0750-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cPartners\u00ae Alcohol Pads 75% Ethyl Alcohol\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0750-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-partners-alcohol-pads-75-ethyl-alcohol\/\">FDA Advisory No.2024-0750-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cPartners\u00ae Alcohol Pads 75% Ethyl Alcohol\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85922","class":"post-row post-type-post post-85922 publish"},"date":" 8 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750.png\" class=\"\" alt=\"FDA Advisory No.2024-0750 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cPartners\u00ae Alcohol Pads 75% Ethyl Alcohol\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0750\" data-caption=\"FDA Advisory No.2024-0750 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cPartners\u00ae Alcohol Pads 75% Ethyl Alcohol\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0750-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-partners-alcohol-pads-75-ethyl-alcohol\/\">FDA Advisory No.2024-0750 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cPartners\u00ae Alcohol Pads 75% Ethyl Alcohol\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85907","class":"post-row post-type-post post-85907 publish"},"date":" 8 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0754-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201c1500I.U.\/0.75ML Solution for Injection (I.M.\/S.C.)\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0754-A\" data-caption=\"FDA Advisory No.2024-0754-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201c1500I.U.\/0.75ML Solution for Injection (I.M.\/S.C.)\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0754-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-1500i-u-0-75ml-solution-for-injection-i-m-s-c\/\">FDA Advisory No.2024-0754-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201c1500I.U.\/0.75ML Solution for Injection (I.M.\/S.C.)\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85900","class":"post-row post-type-post post-85900 publish"},"date":" 8 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754.png\" class=\"\" alt=\"FDA Advisory No.2024-0754 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cTetanus Antitoxin 1500I.U.\/0.75ML Solution for Injection (I.M.\/S.C.)\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0754\" data-caption=\"FDA Advisory No.2024-0754 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cTetanus Antitoxin 1500I.U.\/0.75ML Solution for Injection (I.M.\/S.C.)\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0754-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-tetanus-antitoxin-1500i-u-0-75ml-solution-for-injection-i-m-s-c\/\">FDA Advisory No.2024-0754 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cTetanus Antitoxin 1500I.U.\/0.75ML Solution for Injection (I.M.\/S.C.)\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85895","class":"post-row post-type-post post-85895 publish"},"date":" 8 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0753-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na \u201cAnti-Rabies Serum (Equine) (Equirab) 200 IU\/mL (1000 IU\/5mL) Solution for Injection (I.M.\/S.C.) 5 mL Vial\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0753-A\" data-caption=\"FDA Advisory No.2024-0753-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na \u201cAnti-Rabies Serum (Equine) (Equirab) 200 IU\/mL (1000 IU\/5mL) Solution for Injection (I.M.\/S.C.) 5 mL Vial\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0753-a-babala-sa-publiko-tungkol-sa-paggamit-ng-beripikadong-pekeng-gamot-na-anti-rabies-serum-equine-equirab-200-iu-ml-1000-iu-5ml-solution-for-injection-i-m\/\">FDA Advisory No.2024-0753-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na \u201cAnti-Rabies Serum (Equine) (Equirab) 200 IU\/mL (1000 IU\/5mL) Solution for Injection (I.M.\/S.C.) 5 mL Vial\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85890","class":"post-row post-type-post post-85890 publish"},"date":" 8 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753.png\" class=\"\" alt=\"FDA Advisory No.2024-0753 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product \u201cAnti-Rabies Serum (Equine) (Equirab) 200 IU\/mL (1000 IU\/5mL) Solution for Injection (I.M.\/S.C.) 5 mL Vial\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0753\" data-caption=\"FDA Advisory No.2024-0753 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product \u201cAnti-Rabies Serum (Equine) (Equirab) 200 IU\/mL (1000 IU\/5mL) Solution for Injection (I.M.\/S.C.) 5 mL Vial\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0753-public-health-warning-against-the-purchase-and-use-of-the-counterfeit-drug-product-anti-rabies-serum-equine-equirab-200-iu-ml-1000-iu-5ml-solution-for-injec\/\">FDA Advisory No.2024-0753 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product \u201cAnti-Rabies Serum (Equine) (Equirab) 200 IU\/mL (1000 IU\/5mL) Solution for Injection (I.M.\/S.C.) 5 mL Vial\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85861","class":"post-row post-type-post post-85861 publish"},"date":" 8 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0749.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0749.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0749.png\" class=\"\" alt=\"FDA Advisory No.2024-0749 || Pest Control Operators (PCO) Regulatory Updates\" loading=\"lazy\" title=\"FDA Advisory No.2024-0749\" data-caption=\"FDA Advisory No.2024-0749 || Pest Control Operators (PCO) Regulatory Updates\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0749.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0749.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0749.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0749-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0749-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0749-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0749-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0749-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0749-pest-control-operators-pco-regulatory-updates\/\">FDA Advisory No.2024-0749 || Pest Control Operators (PCO) Regulatory Updates<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85830","class":"post-row post-type-post post-85830 publish"},"date":" 7 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0748.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0748.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0748.png\" class=\"\" alt=\"FDA Advisory No.2024-0748 || Pilot Implementation of the Electronic Certificate of Product Registration (E-CPR) Information System for the Application for Initial Registration of Generic Prescription Drugs for Human Use from 07 May 2024 to 07 August 2024\" loading=\"lazy\" title=\"FDA Advisory No.2024-0748\" data-caption=\"FDA Advisory No.2024-0748 || Pilot Implementation of the Electronic Certificate of Product Registration (E-CPR) Information System for the Application for Initial Registration of Generic Prescription Drugs for Human Use from 07 May 2024 to 07 August 2024\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0748.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0748.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0748.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0748-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0748-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0748-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0748-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0748-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0748-pilot-implementation-of-the-electronic-certificate-of-product-registration-e-cpr-information-system-for-the-application-for-initial-registration-of-generic-prescription\/\">FDA Advisory No.2024-0748 || Pilot Implementation of the Electronic Certificate of Product Registration (E-CPR) Information System for the Application for Initial Registration of Generic Prescription Drugs for Human Use from 07 May 2024 to 07 August 2024<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85825","class":"post-row post-type-post post-85825 publish"},"date":" 7 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0573.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0573.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0573.png\" class=\"\" alt=\"FDA Advisory No.2024-0573 || Call for Nomination as member of the Animal Health Product Advisory Committee (AHPAC)\" loading=\"lazy\" title=\"FDA Advisory No.2024-0573\" data-caption=\"FDA Advisory No.2024-0573 || Call for Nomination as member of the Animal Health Product Advisory Committee (AHPAC)\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0573.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0573.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0573.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0573-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0573-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0573-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0573-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0573-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0573-call-for-nomination-as-member-of-the-animal-health-product-advisory-committee-ahpac\/\">FDA Advisory No.2024-0573 || Call for Nomination as member of the Animal Health Product Advisory Committee (AHPAC)<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85821","class":"post-row post-type-post post-85821 publish"},"date":" 7 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0558.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0558.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0558.png\" class=\"\" alt=\"FDA Advisory No.2024-0558 || Call for Nomination as member of the Human Drug Registration Advisory Committee (HDRAC)\" loading=\"lazy\" title=\"FDA Advisory No.2024-0558\" data-caption=\"FDA Advisory No.2024-0558 || Call for Nomination as member of the Human Drug Registration Advisory Committee (HDRAC)\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0558.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0558.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0558.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0558-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0558-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0558-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0558-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0558-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0558-call-for-nomination-as-member-of-the-human-drug-registration-advisory-committee-hdrac\/\">FDA Advisory No.2024-0558 || Call for Nomination as member of the Human Drug Registration Advisory Committee (HDRAC)<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85802","class":"post-row post-type-post post-85802 publish"},"date":" 6 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0747-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cOTC Erythromycin Ointment 5g\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0747-A\" data-caption=\"FDA Advisory No.2024-0747-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cOTC Erythromycin Ointment 5g\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0747-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-otc-erythromycin-ointment-5g\/\">FDA Advisory No.2024-0747-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cOTC Erythromycin Ointment 5g\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85798","class":"post-row post-type-post post-85798 publish"},"date":" 6 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747.png\" class=\"\" alt=\"FDA Advisory No.2024-0747 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cOTC Erythromycin Ointment 5g\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0747\" data-caption=\"FDA Advisory No.2024-0747 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cOTC Erythromycin Ointment 5g\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0747-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-otc-erythromycin-ointment-5g\/\">FDA Advisory No.2024-0747 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cOTC Erythromycin Ointment 5g\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85792","class":"post-row post-type-post post-85792 publish"},"date":" 6 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0746-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-0746-A\" data-caption=\"FDA Advisory No.2024-0746-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0746-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-0746-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85786","class":"post-row post-type-post post-85786 publish"},"date":" 6 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746.png\" class=\"\" alt=\"FDA Advisory No.2024-0746 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-0746\" data-caption=\"FDA Advisory No.2024-0746 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0746-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-0746 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85780","class":"post-row post-type-post post-85780 publish"},"date":" 6 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0745-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-0745-A\" data-caption=\"FDA Advisory No.2024-0745-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0745-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-0745-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85774","class":"post-row post-type-post post-85774 publish"},"date":" 6 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745.png\" class=\"\" alt=\"FDA Advisory No.2024-0745 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-0745\" data-caption=\"FDA Advisory No.2024-0745 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0745-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-0745 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85770","class":"post-row post-type-post post-85770 publish"},"date":" 6 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0744-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cNANZ i-Drops 15ml\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0744-A\" data-caption=\"FDA Advisory No.2024-0744-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cNANZ i-Drops 15ml\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0744-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-nanz-i-drops-15ml\/\">FDA Advisory No.2024-0744-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cNANZ i-Drops 15ml\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85766","class":"post-row post-type-post post-85766 publish"},"date":" 6 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744.png\" class=\"\" alt=\"FDA Advisory No.2024-0744 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cNANZ i-Drops 15mL\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0744\" data-caption=\"FDA Advisory No.2024-0744 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cNANZ i-Drops 15mL\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0744-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-nanz-i-drops-15ml\/\">FDA Advisory No.2024-0744 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cNANZ i-Drops 15mL\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85760","class":"post-row post-type-post post-85760 publish"},"date":" 6 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0743-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-0743-A\" data-caption=\"FDA Advisory No.2024-0743-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0743-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-0743-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85754","class":"post-row post-type-post post-85754 publish"},"date":" 6 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743.png\" class=\"\" alt=\"FDA Advisory No.2024-0743 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-0743\" data-caption=\"FDA Advisory No.2024-0743 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0743-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-0743 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85750","class":"post-row post-type-post post-85750 publish"},"date":" 6 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0742-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0742-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0742-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0742-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cRecombinant Human Erythropoietin Injection IP 4000 IU (Renocrit \u2122 4000) Single dose pre-filled syringe of 4000 IU\/ 0.4 mL\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0742-A\" data-caption=\"FDA Advisory No.2024-0742-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cRecombinant Human Erythropoietin Injection IP 4000 IU (Renocrit \u2122 4000) Single dose pre-filled syringe of 4000 IU\/ 0.4 mL\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0742-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0742-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0742-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0742-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0742-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0742-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0742-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0742-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0742-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-recombinant-human-erythropoietin-injection-ip-4000-iu-renocrit-4000-sin\/\">FDA Advisory No.2024-0742-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cRecombinant Human Erythropoietin Injection IP 4000 IU (Renocrit \u2122 4000) Single dose pre-filled syringe of 4000 IU\/ 0.4 mL\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85746","class":"post-row post-type-post post-85746 publish"},"date":" 6 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0742.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0742.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0742.png\" class=\"\" alt=\"FDA Advisory No.2024-0742 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cRecombinant Human Erythropoietin Injection IP 4000 IU (Renocrit \u2122 4000) Single dose pre-filled syringe of 4000 IU\/ 0.4 mL\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0742\" data-caption=\"FDA Advisory No.2024-0742 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cRecombinant Human Erythropoietin Injection IP 4000 IU (Renocrit \u2122 4000) Single dose pre-filled syringe of 4000 IU\/ 0.4 mL\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0742.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0742.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0742.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0742-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0742-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0742-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0742-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0742-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0742-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-recombinant-human-erythropoietin-injection-ip-4000-iu-renocrit-4000\/\">FDA Advisory No.2024-0742 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cRecombinant Human Erythropoietin Injection IP 4000 IU (Renocrit \u2122 4000) Single dose pre-filled syringe of 4000 IU\/ 0.4 mL\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85738","class":"post-row post-type-post post-85738 publish"},"date":" 3 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0741.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0741.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0741.png\" class=\"\" alt=\"FDA Advisory No.2024-0741 || Product Recall of All Available Batches of Methotrexate           100 mg\/mL Solution for Injection (IM\/IV) [Trexasaph]\" loading=\"lazy\" title=\"FDA Advisory No.2024-0741\" data-caption=\"FDA Advisory No.2024-0741 || Product Recall of All Available Batches of Methotrexate           100 mg\/mL Solution for Injection (IM\/IV) [Trexasaph]\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0741.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0741.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0741.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0741-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0741-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0741-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0741-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0741-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0741-product-recall-of-all-available-batches-of-methotrexate-100-mg-ml-solution-for-injection-im-iv-trexasaph\/\">FDA Advisory No.2024-0741 || Product Recall of All Available Batches of Methotrexate           100 mg\/mL Solution for Injection (IM\/IV) [Trexasaph]<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85733","class":"post-row post-type-post post-85733 publish"},"date":" 3 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0740.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0740.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0740.png\" class=\"\" alt=\"FDA Advisory No.2024-0740 || Product Recall of Specific Lot of Enalapril Maleate 10 mg Tablet [Scheepril]\" loading=\"lazy\" title=\"FDA Advisory No.2024-0740\" data-caption=\"FDA Advisory No.2024-0740 || Product Recall of Specific Lot of Enalapril Maleate 10 mg Tablet [Scheepril]\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0740.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0740.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0740.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0740-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0740-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0740-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0740-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0740-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0740-product-recall-of-specific-lot-of-enalapril-maleate-10-mg-tablet-scheepril\/\">FDA Advisory No.2024-0740 || Product Recall of Specific Lot of Enalapril Maleate 10 mg Tablet [Scheepril]<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85729","class":"post-row post-type-post post-85729 publish"},"date":" 3 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0739.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0739.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0739.png\" class=\"\" alt=\"FDA Advisory No.2024-0739 || Voluntary Recall of Bibigo Mandu Prawn Dumplings, Bibigo Mini Mandu Prawn - Quick Frozen Korean Dumplings Filled with Prawn, and Cau Tre Seafood Net Spring Roll\" loading=\"lazy\" title=\"FDA Advisory No.2024-0739\" data-caption=\"FDA Advisory No.2024-0739 || Voluntary Recall of Bibigo Mandu Prawn Dumplings, Bibigo Mini Mandu Prawn - Quick Frozen Korean Dumplings Filled with Prawn, and Cau Tre Seafood Net Spring Roll\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0739.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0739.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0739.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0739-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0739-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0739-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0739-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0739-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0739-voluntary-recall-of-bibigo-mandu-prawn-dumplings-bibigo-mini-mandu-prawn-quick-frozen-korean-dumplings-filled-with-prawn-and-cau-tre-seafood-net-spring-roll\/\">FDA Advisory No.2024-0739 || Voluntary Recall of Bibigo Mandu Prawn Dumplings, Bibigo Mini Mandu Prawn &#8211; Quick Frozen Korean Dumplings Filled with Prawn, and Cau Tre Seafood Net Spring Roll<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/food-advisories\/\" rel=\"category tag\">Food Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85721","class":"post-row post-type-post post-85721 publish"},"date":" 3 May 2024","image":"","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0738-public-health-warning-against-the-purchase-and-consumption-of-the-unregistered-food-product-boracay-brew-mango-kombucha\/\">FDA Advisory No.2024-0738 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product \u201cBORACAY BREW Mango Kombucha\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/food-advisories\/\" rel=\"category tag\">Food Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85714","class":"post-row post-type-post post-85714 publish"},"date":" 2 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0703.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0703.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0703.png\" class=\"\" alt=\"FDA Advisory No.2024-0703 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &quot;TEAZEN Grapefruit&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-0703\" data-caption=\"FDA Advisory No.2024-0703 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &quot;TEAZEN Grapefruit&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0703.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0703.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0703.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0703-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0703-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0703-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0703-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0703-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0703-public-health-warning-against-the-purchase-and-consumption-of-the-unregistered-food-product-teazen-grapefruit\/\">FDA Advisory No.2024-0703 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &#8220;TEAZEN Grapefruit&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/food-advisories\/\" rel=\"category tag\">Food Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85710","class":"post-row post-type-post post-85710 publish"},"date":" 2 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0702.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0702.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0702.png\" class=\"\" alt=\"FDA Advisory No.2024-0702 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &quot;ASIAN HOME GOURMET Spice Paste for  Indian Tikka Masala Mild&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-0702\" data-caption=\"FDA Advisory No.2024-0702 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &quot;ASIAN HOME GOURMET Spice Paste for  Indian Tikka Masala Mild&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0702.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0702.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0702.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0702-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0702-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0702-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0702-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0702-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0702-public-health-warning-against-the-purchase-and-consumption-of-the-unregistered-food-product-asian-home-gourmet-spice-paste-for-indian-tikka-masala-mild\/\">FDA Advisory No.2024-0702 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &#8220;ASIAN HOME GOURMET Spice Paste for  Indian Tikka Masala Mild&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/food-advisories\/\" rel=\"category tag\">Food Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85706","class":"post-row post-type-post post-85706 publish"},"date":" 2 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0701.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0701.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0701.png\" class=\"\" alt=\"FDA Advisory No.2024-0701 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &quot;SUNDRY Barbecue Powder&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-0701\" data-caption=\"FDA Advisory No.2024-0701 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &quot;SUNDRY Barbecue Powder&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0701.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0701.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0701.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0701-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0701-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0701-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0701-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0701-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0701-public-health-warning-against-the-purchase-and-consumption-of-the-unregistered-food-product-sundry-barbecue-powder\/\">FDA Advisory No.2024-0701 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &#8220;SUNDRY Barbecue Powder&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/food-advisories\/\" rel=\"category tag\">Food Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85702","class":"post-row post-type-post post-85702 publish"},"date":" 2 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0700.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0700.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0700.png\" class=\"\" alt=\"FDA Advisory No.2024-0700 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &quot;SASMUAN DELICACIES Short Bread  Cookies Polvoron Pinipig&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-0700\" data-caption=\"FDA Advisory No.2024-0700 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &quot;SASMUAN DELICACIES Short Bread  Cookies Polvoron Pinipig&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0700.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0700.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0700.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0700-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0700-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0700-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0700-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0700-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0700-public-health-warning-against-the-purchase-and-consumption-of-the-unregistered-food-product-sasmuan-delicacies-short-bread-cookies-polvoron-pinipig\/\">FDA Advisory No.2024-0700 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &#8220;SASMUAN DELICACIES Short Bread  Cookies Polvoron Pinipig&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/food-advisories\/\" rel=\"category tag\">Food Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85698","class":"post-row post-type-post post-85698 publish"},"date":" 2 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0699.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0699.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0699.png\" class=\"\" alt=\"FDA Advisory No.2024-0699 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &quot;COLES Ultimate Cookies (40% Triple  Chocolate Chips - Crunchy Chocolate Cookies, packed with Dark, Milk &amp;  White Chocolate Chips)&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-0699\" data-caption=\"FDA Advisory No.2024-0699 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &quot;COLES Ultimate Cookies (40% Triple  Chocolate Chips - Crunchy Chocolate Cookies, packed with Dark, Milk &amp;  White Chocolate Chips)&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0699.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0699.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0699.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0699-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0699-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0699-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0699-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0699-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0699-public-health-warning-against-the-purchase-and-consumption-of-the-unregistered-food-product-coles-ultimate-cookies-40-triple-chocolate-chips-crunchy-chocolate-cooki\/\">FDA Advisory No.2024-0699 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &#8220;COLES Ultimate Cookies (40% Triple  Chocolate Chips &#8211; Crunchy Chocolate Cookies, packed with Dark, Milk &#038;  White Chocolate Chips)&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/food-advisories\/\" rel=\"category tag\">Food Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85694","class":"post-row post-type-post post-85694 publish"},"date":" 2 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0698.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0698.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0698.png\" class=\"\" alt=\"FDA Advisory No.2024-0698 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &quot;GOLDEN HANDS KAMAYAN Salted Shrimp  Fry Bagoong Alamang&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-0698\" data-caption=\"FDA Advisory No.2024-0698 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &quot;GOLDEN HANDS KAMAYAN Salted Shrimp  Fry Bagoong Alamang&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0698.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0698.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0698.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0698-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0698-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0698-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0698-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0698-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0698-public-health-warning-against-the-purchase-and-consumption-of-the-unregistered-food-product-golden-hands-kamayan-salted-shrimp-fry-bagoong-alamang\/\">FDA Advisory No.2024-0698 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &#8220;GOLDEN HANDS KAMAYAN Salted Shrimp  Fry Bagoong Alamang&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/food-advisories\/\" rel=\"category tag\">Food Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85690","class":"post-row post-type-post post-85690 publish"},"date":" 2 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0697.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0697.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0697.png\" class=\"\" alt=\"FDA Advisory No.2024-0697 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &quot;TSOKOMAN Chocnut Palaman&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-0697\" data-caption=\"FDA Advisory No.2024-0697 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &quot;TSOKOMAN Chocnut Palaman&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0697.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0697.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0697.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0697-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0697-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0697-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0697-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0697-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0697-public-health-warning-against-the-purchase-and-consumption-of-the-unregistered-food-product-tsokoman-chocnut-palaman\/\">FDA Advisory No.2024-0697 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &#8220;TSOKOMAN Chocnut Palaman&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/food-advisories\/\" rel=\"category tag\">Food Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85686","class":"post-row post-type-post post-85686 publish"},"date":" 2 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0696.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0696.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0696.png\" class=\"\" alt=\"FDA Advisory No.2024-0696 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &quot;ALAMANG PH Shrimp Paste Sweet and  Spicy&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-0696\" data-caption=\"FDA Advisory No.2024-0696 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &quot;ALAMANG PH Shrimp Paste Sweet and  Spicy&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0696.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0696.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0696.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0696-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0696-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0696-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0696-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0696-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0696-public-health-warning-against-the-purchase-and-consumption-of-the-unregistered-food-product-alamang-ph-shrimp-paste-sweet-and-spicy\/\">FDA Advisory No.2024-0696 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &#8220;ALAMANG PH Shrimp Paste Sweet and  Spicy&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/food-advisories\/\" rel=\"category tag\">Food Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85682","class":"post-row post-type-post post-85682 publish"},"date":" 2 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0695.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0695.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0695.png\" class=\"\" alt=\"FDA Advisory No.2024-0695 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &quot;JANGMI&#039;S Special Peanut Butter&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-0695\" data-caption=\"FDA Advisory No.2024-0695 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &quot;JANGMI&#039;S Special Peanut Butter&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0695.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0695.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0695.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0695-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0695-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0695-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0695-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0695-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0695-public-health-warning-against-the-purchase-and-consumption-of-the-unregistered-food-product-jangmis-special-peanut-butter\/\">FDA Advisory No.2024-0695 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &#8220;JANGMI&#8217;S Special Peanut Butter&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/food-advisories\/\" rel=\"category tag\">Food Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85678","class":"post-row post-type-post post-85678 publish"},"date":" 2 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0694.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0694.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0694.png\" class=\"\" alt=\"FDA Advisory No.2024-0694 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &quot;LOLA GIE Gin-C&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-0694\" data-caption=\"FDA Advisory No.2024-0694 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &quot;LOLA GIE Gin-C&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0694.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0694.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0694.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0694-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0694-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0694-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0694-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0694-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0694-public-health-warning-against-the-purchase-and-consumption-of-the-unregistered-food-product-lola-gie-gin-c\/\">FDA Advisory No.2024-0694 || Public Health Warning Against the Purchase and Consumption of the  Unregistered Food Product &#8220;LOLA GIE Gin-C&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/food-advisories\/\" rel=\"category tag\">Food Advisories<\/a>","categories_hfilter":""}]}
